Portman Square Capital LLP Alnylam Pharmaceuticals, Inc. Transaction History
Portman Square Capital LLP
- $2.47 Billion
- Q3 2024
A detailed history of Portman Square Capital LLP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Portman Square Capital LLP holds 8,513 shares of ALNY stock, worth $2.32 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
8,513
Previous 11,848
28.15%
Holding current value
$2.32 Million
Previous $2.88 Million
18.69%
% of portfolio
0.09%
Previous 0.11%
Shares
7 transactions
Others Institutions Holding ALNY
# of Institutions
639Shares Held
107MCall Options Held
2.33MPut Options Held
2.15M-
Capital World Investors Los Angeles, CA15MShares$4.08 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.4 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.6 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.69 Billion0.28% of portfolio
-
Baillie Gifford & CO4.89MShares$1.33 Billion1.03% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...